ELLEN FLANNERY, EDITOR

For our July cover, we host Lyle McMillin, AVP of Product Management at Hyland Healthcare, who shares insights from a career at the intersection of technology and healthcare. He discusses the power of data-driven leadership, and the value of nurturing talent and offers advice for startups. McMillin also explores how AI innovations at Hyland are transforming clinical documentation, medical imaging and operational efficiency across the healthcare landscape.

“ By fostering an environment where individuals can thrive and contribute their best, I’ ve seen firsthand how collective talent and diverse perspectives can drive remarkable achievements,” said McMillin.

Read more on page 48.

MolecuLight, a global pioneer in point-ofcare fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company, congratulated researchers at Shuang-Ho Hospital in Taipei, Taiwan, on their publication of ground-breaking findings using MolecuLight. The clinical study demonstrates the transformative impact of MolecuLight’ s device on the management of deep sternal wound infections( DSWI), showcasing significantly improved patient outcomes alongside cost savings and reduced burden on the healthcare system. Read more on page 39.

As the cost-of-living increases, so does the grip of the US healthcare system on its users. I ask three experts to share their insights on how BNPL and instalment payment models are supporting or hindering citizens with their health insurance and what it means for North American society. This month’ s Editor’ s Question asks: How are digital BNPL and instalment payment models impacting healthcare costs and insurance in the US? Find out what they had to say on page 25.

With increasing populations, financial pressures and strains on workforces, BioTech leaders should not overlook their Digital Transformation journeys. On page 63, Kevin Cramer, CEO of Sapio Sciences, discusses how AI, cloud and real-time analytics are reshaping the future of healthcare.

The global digital pathology market is projected to be valued at US $ 1.10 billion in 2024 and reach US $ 1.73 billion by 2030, growing at a CAGR of 8 % according to a new report by The

TO OUR MONTHLY MAGAZINE

Research Insights. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is the integration of Artificial Intelligence( AI) in digital pathology systems, which boosts diagnostics through automated image analysis and predictive analytics. Read further insights for this report on page 63.

We also have a range of‘ Intelligent’ pages, which feature the latest in Artificial Intelligence, cloud, wearable technology, robotics, security and Virtual Reality.

I hope you enjoy this issue and if you want to contribute to any future editions, please contact me.

Ellen Flannery, Editor

www. intelligenthealth. tech 3